Corvus Pharmaceuticals Inc buy Cantor Fitzgerald
Start price
01.04.24
/
50%
€1.67
Target price
01.04.25
-
Performance (%)
71.74%
End price
02.04.25
€2.88
Summary
This prediction ended on 02.04.25 with a price of €2.88. With a performance of 71.74% the BUY prediction by Cantor_Fitzgerald was a big success. Cantor_Fitzgerald has a follow-up prediction for Corvus Pharmaceuticals Inc where he still thinks Corvus Pharmaceuticals Inc is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | 1.014% | 1.014% | 373.663% |
| iShares Core DAX® | 4.852% | -4.418% | 13.097% |
| iShares Nasdaq 100 | 3.999% | -3.283% | 31.335% |
| iShares Nikkei 225® | 4.221% | -6.223% | 44.472% |
| iShares S&P 500 | 3.324% | -3.174% | 24.360% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€7.16
11.12.25
11.12.25
-
11.12.26
11.12.26
73.74%
02.04.26
02.04.26
Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.51
07.09.23
07.09.23
€3.74
07.09.24
07.09.24
146.36%
08.09.24
08.09.24